Stay updated on the latest game-changing updates in the life science industry!
1. FG secures $240m investment for local manufacturing of pharmaceuticals.
The federal government on Wednesday disclosed that it has secured a $240 million investment from a Brazilian pharmaceutical for local manufacturing of generic pharmaceuticals.
READ MORE.
2. Hiring:
Medical Content Writer (Remote) at Mopheth Nigeria Limited.
Location: Remote.
Employment Type: Full-time.
Remote Start Date: March 20th, 2024.
Bachelor’s degree in a relevant field such as Medicine, Biology, or Journalism.
3 – 6 years of experience working in a health-related role, preferably as a medical writer or content creator for a health app.
Strong writing and editing skills, with the ability to communicate complex medical information clearly and concisely.
Applications, Resume and Cover Letters detailing their relevant experience and why they are the ideal candidate for this role to: ayok@mophethgroup.com
Using the Job Title as the subject of the email.
3. Nigerian Customs Operatives Intercept Fake Pharmaceutical Products Worth N1.4billion In Oyo-Osun Axis.
The Nigeria Customs Service has announced the interception of fake pharmaceuticals with duty paid value of N1.4 billion at its Oyo-Osun Area Command.
The Oyo-Osun Area Controller, Dr Ben Oramalugo, who disclosed this on Wednesday, while briefing reporters, said
READ MORE.
4. House C’ttee On Environment Visits NBMA To Enhance Biosafety Regulations.
The House of Representatives Committee on Environment has paid a visit to the National Biosafety Management Agency (NBMA) at its head office in Abuja, to oversee and enhance biosafety regulations in the country.
READ MORE.
5. Antibiotic costs rise 1100% as big pharma exits Nigeria.
In Nigeria, the rapidly escalating drug prices are indicative of a deeper issue: fundamentally, it’s about the economy. The situation shows no signs of abating, especially as recent reports in January 2024 indicated inflation has surged to a 27 year high of 28.92%.
READ MORE.
6. Experts warn against proposed merger of NABDA, NACGRAB, say it’s dangerous to biosafety.
Environmental experts have highlighted the dangers of merging the National Biotechnology Development Agency, NABDA, and National Centre for Genetic Resources and Biotechnology, NACGRAB, as National Biotechnology Research and Development Agency, NBRDA.
READ MORE.
This blog post is in line with our mission to keep you updated on the latest developments and trends in the life science industry.
Stay tuned and follow us at Life Science Nigeria so you don’t miss timely updates.